Cat.#: ACPP-1309
| Despition | CCR5 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1656 | Human MAPT Protein (AC1656) | 2 µg | inquiry |
| ACPP-1305 | Aph 1b Blocking Peptide (AC1305) | 250 µg | inquiry |
| ACPP-1009 | Recombinant Human TYRO3 Protein (6×His Tag) (AC1009) | 50 µg | inquiry |
| ACPP-1040 | Recombinant Mouse Eph Receptor A2 Protein (6×His Tag) (AC1040) | 50 µg | inquiry |
| ACPP-1716 | Mouse ANGPTL7 Protein (AC1716) | 1 µg | inquiry |
| ACPP-1299 | Calretinin Blocking Peptide (AC1299) | 250 µg | inquiry |
| ACPP-1646 | Human DNAJB6 Protein (AC1646) | 1 µg | inquiry |
| ACPP-1815 | Human HAAO Protein (AC1815) | 2 µg | inquiry |
| ACPP-1370 | EFEMP1 Blocking Peptide (AC1370) | 250 µg | inquiry |
| ACPP-1745 | Mouse Acrp30 Protein, His (AC1745) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.